UBC Medical Indonesia Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp164 (market cap 651.75B, 126.8K 24h volume), while Yanaprima Hastapersada Tbk trades at Rp1,200 (market cap 641.28B, 889.9K 24h volume). The key difference: UBC Medical Indonesia Tbk. and Yanaprima Hastapersada Tbk are close in size by market cap, and Yanaprima Hastapersada Tbk is more actively traded (889.9K versus 126.8K). Which is the better fit depends on your goals.
| LABS | YPAS | |
|---|---|---|
Market Cap | 651.75B | 641.28B |
Volume | 126.8K | 889.9K |
Lot | 1.27K | 8.9K |
Turnover | 20.89M | 1.06B |
Average Price | 164.76 | 1,193 |
Value | 20.89M | 1.06B |
Indicative Equilibrium Price | 165 | 1,190 |
Indicative Equilibrium Volume | 300 | 212 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Read more on YPAS →